본문 바로가기
KERD
논문KCI 등재

SCORing atopic dermatitis index로 평가한 아토피피부염의 중증도와 혈액 검사와의 연관성

The correlation between the severity of atopic dermatitis classified by SCORing atopic dermatitis index and the laboratory tests

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: SCORing atopic dermatitis (SCORAD) index is the best validated scoring system in atopic dermatitis (AD). But this scoring system has limitation to the interobserver and intraobserver variation. This study was designed to evaluate the correlation between the severity of AD classified by the SCORAD index and the laboratory tests. Methods: We evaluated 67 children admitted in the pediatric allergy and respiratory division of Busan St. Mary’s Medical Center from April 1 to 30, 2011. SCORAD index was measured by one same physician. The patients were classified into mild to moderate and severe groups by SCORAD index. We identified sex, age and family history of allergic disease. We checked laboratory tests including mycoplasma immunoglobulin (Ig) M, total IgE, eosinophil count, eosinophil cationic protein, specific IgE, total protein, albumin, IgG, IgA, IgM, IgD, and inflammatory index (lactate dehydrogenase, C-reactive protein, erythrocyte sedimentation rate) and skin culture. Results: There were no statistically significant differences between two groups in age, sex, parental allergic history, skin culture, mycoplasma IgM, specific IgE, immunoglobulin, and inflammatory index. The SCORAD index has statistically significant positive correlations with serum total eosinophil count, and total IgE, and negative correlations with total protein, and albumin. Conclusion: Our study suggest that serum total eosinophil count, total IgE, total protein, and albumin can be used to evaluate the severity of AD and make up for the SCORAD index.

Abstract

Purpose: SCORing atopic dermatitis (SCORAD) index is the best validated scoring system in atopic dermatitis (AD). But this scoring system has limitation to the interobserver and intraobserver variation. This study was designed to evaluate the correlation between the severity of AD classified by the SCORAD index and the laboratory tests. Methods: We evaluated 67 children admitted in the pediatric allergy and respiratory division of Busan St. Mary’s Medical Center from April 1 to 30, 2011. SCORAD index was measured by one same physician. The patients were classified into mild to moderate and severe groups by SCORAD index. We identified sex, age and family history of allergic disease. We checked laboratory tests including mycoplasma immunoglobulin (Ig) M, total IgE, eosinophil count, eosinophil cationic protein, specific IgE, total protein, albumin, IgG, IgA, IgM, IgD, and inflammatory index (lactate dehydrogenase, C-reactive protein, erythrocyte sedimentation rate) and skin culture. Results: There were no statistically significant differences between two groups in age, sex, parental allergic history, skin culture, mycoplasma IgM, specific IgE, immunoglobulin, and inflammatory index. The SCORAD index has statistically significant positive correlations with serum total eosinophil count, and total IgE, and negative correlations with total protein, and albumin. Conclusion: Our study suggest that serum total eosinophil count, total IgE, total protein, and albumin can be used to evaluate the severity of AD and make up for the SCORAD index.

참고문헌 (34)

  1. Williams HC, "Clinical practice. Atopic dermatitis", N Engl J Med, 352, pp.2314~2324 (2005)
  2. Leung DY, "Atopic dermatitis", Lancet, 361, pp.151~160 (2003)
  3. Leung DY, "New insights into atopic dermatitis", J Clin Invest, 113, pp.651~657 (2004)
  4. Mozaffari H, "Quality of life in atopic dermatitis patients", J Microbiol Immunol Infect, 40, pp.260~264 (2007)
  5. Beattie PE, "A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases", Br J Dermatol, 155, pp.145~151 (2006)
  6. Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Derm Venereol Suppl, 92, pp.44~47 (1980)
  7. Finlay AY, "Measurement of disease activity and outcome in atopic dermatitis", Br J Dermatol, 135, pp.509~515 (1996)
  8. Chren MM, "Giving "scale" new meaning in dermatology: measurement matters", Arch Dermatol, 136, pp.788~790 (2000)
  9. Charman C, "Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?", J Invest Dermatol, 120, pp.932~941 (2003)
  10. "Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis", Dermatology, 186, pp.23~31 (1993)
  11. Oranje AP, "Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child", Pediatr Allergy Immunol, 8, pp.28~34 (1997)
  12. Wüthrich B, "The atopic eczema", dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS, 2003, pp.13, 1~5
  13. 남승연, "학동 전기 소아에서의 알레르기 질환의 유병률과 위험 인자에 관한 연구", Allergy Asthma & Respiratory Diseases, 15(4), pp.439~445 (2005), 대한 소아알레르기 호흡기학회
  14. Kapoor R, "The prevalence of atopic triad in children with physician-confirmed atopic dermatitis", J Am Acad Dermatol, 58, pp.68~73 (2008)
  15. 김동일, "다 기관 설문 조사를 통한 알레르기 질환의 연령별 임상 양상", Korean Journal of Pediatrics, 51(6), pp.640~645 (2008), 대한소아과학회
  16. Gustafsson D, "Development of allergies and asthma in infants and young children with atopic dermatitis: a prospective follow-up to 7 years of age", Allergy, 55, pp.240~245 (2000)
  17. Illi S, "The natural course of atopic dermatitis from birth to age 7 years and the association with asthma", J Allergy Clin Immunol, 113, pp.925~931 (2004)
  18. Noh GW, "Blood eosinophils and serum IgE as predictors for prognosis of interferon-gamma therapy in atopic dermatitis", Allergy, 53, pp.1202~1207 (1998)
  19. Gutgesell C, "Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores", Br J Dermatol, 147, pp.914~919 (2002)
  20. Gebhardt M, "Monitoring of serologic immune parameters in inflammatory skin diseases", Allergy, 52, pp.1087~1094 (1997)
  21. Lee JH, "A study on the relationship of the severity of atopic dermatitis, serum IgE and IFN-gamma", Korean J Dermatol, 39, pp.1067~1071 (2001)
  22. 김명남, "아토피 피부염에서 말초 혈액내 호산구 수, 혈청 총 IgE, eosinophil cationic protein, IL-4 및 soluble E-selectin의 변화", 대한피부과학회지, 40(11), pp.1367~1373 (2002), 대한피부과학회
  23. Simon D, "Eosinophils and atopic dermatitis", Allergy, 59, pp.561~570 (2004)
  24. Gleich GJ, "The eosinophilic leukocyte: structure and function", Adv Immunol, 39, pp.177~253 (1986)
  25. Czech W, "Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis", Br J Dermatol, 126, pp.351~355 (1992)
  26. Nomura I, "Hypoproteinemia in severe childhood atopic dermatitis: a serious complication", Pediatr Allergy Immunol, 13, pp.287~294 (2002)
  27. Novembre E, "Severe hypoproteinemia in infant with AD", Allergy, 58, pp.88~89 (2003)
  28. Werfel T, "Role of food allergy in atopic dermatitis", Curr Opin Allergy Clin Immunol, 4, pp.379~385 (2004)
  29. Moghtaderi M, "Specific IgE to common food allergens in children with atopic dermatitis", Iran J Immunol, 9, pp.32~38 (2012)
  30. Leyden JJ, "The case for steroid: antibiotic combinations", Br J Dermatol, 96, pp.179~187 (1977)
  31. Leung DY, "Atopic dermatitis and the immune system: the role of superantigens and bacteria", J Am Acad Dermatol, 45(1 Suppl), pp.S13~16 (2001)
  32. 김영호, "표재성 황색포도구균의 존재와 그 외독소가 소아 아토피피부염에 미치는 영향", Allergy Asthma & Respiratory Diseases, 16(2), pp.162~170 (2006), 대한 소아알레르기 호흡기학회
  33. Biscardi S, "Mycoplasma pneumoniae and asthma in children", Clin Infect Dis, 38, pp.1341~1346 (2004)
  34. 홍수종, "The Role of Mycoplasma pneumoniae Infection in Asthma", Allergy, Asthma & Immunology Research, 4(2), pp.59~61 (2012), 대한천식알레르기학회

관련 논문AI추천

이 간행물의 다른 논문 (16건)